Skip to content

Genworth Financial

US · GNW #2349 by market cap Listed 1970
9.63 0.00 0.00%
Live - 5344 symbols - heartbeat 219s ago · 2026-10-07 20:02
After-hours 9.63 0.00%
Market cap
3.64B
P/B
0.42
EPS
0.54
Reader sentiment Are you bullish or bearish on GNW?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
0.10 fair value ≈ 8.26 16.43
  • Implied fair-value range of 0.10-16.43, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +16.5% above the average-multiple fair value of 8.26.

Valuation each multiple against its own 5-year range

P/B ratio 0.42 Expensive vs history 95th percentile
5-year average 0.31 · #6 of 22 in Insurance - Life
P/E ratio 18.17 Expensive vs history 71st percentile
5-year average 15.30 · forward 28.21 · #13 of 18 in Insurance - Life
P/S ratio 0.49 Expensive vs history 92nd percentile
5-year average 0.38 · #9 of 22 in Insurance - Life

Vs. peers Insurance - Life

Company Market cap P/E (TTM) P/B Div yield
Genworth Financial (GNW) 3.64B 18.17 0.42 0.00%
Manulife Financial (MFC) 68.93B 16.10 2.11 3.13%
MetLife (MET) 60.87B 18.35 2.22 2.40%
Aflac Inc (AFL) 56.52B 12.16 1.86 2.11%
Prudential Financial (PRU) 38.76B 10.19 1.23 4.89%
Prudential (PUK) 29.39B 8.28 1.48 2.26%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value9.66 Economic moatNone UncertaintyMedium

Trading 0.3% below Morningstar's fair value estimate.

Fair value

Genworth Financial Inc receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a medium uncertainty rating.

The firm's valuation metrics strengthen our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 241.6%, which falls in the top 10% compared with peers globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our balanced fair value estimate.

Alternatively, the firm's unfavorable dividend structure is potentially concerning. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, ranks in the bottom 30% compared with peers globally. This could imply a planned dividend cut or relatively high share price, which further promotes our neutral price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. While we believe the stock is fairly-valued, this outperformance had a negative impact on our valuation estimate.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. However, its financial health score is strong, suggesting that the company should be well positioned to weather tough times.

By Quantitative Equity Report

Quote time 2026-10-07 20:02:39 · For reference only, not investment advice and not tailored to your situation.